CPC STUDY COURSE · 2026 EDITION
Bronchodilator response as a diagnostic study
Read an original fictional chart, identify the supported facts, and explain your coding workflow.
Chart gym · Original fictional record
Service date: 2026-09-09 · Outpatient professional or facility service as stated; Medicare relationship
Use your code books and write your reasoning before opening the walkthrough. This exercise contains no real patient information.
Diagnostic order
Fictional adult attends an outpatient laboratory for an ordered bronchodilator-response study to evaluate a documented diagnostic question. The record does not describe treatment of an acute airway-obstruction episode at this visit.
Completed study
The staff obtain the required baseline measurements, administer the bronchodilator used by the study and complete the post-administration measurements. The clinician interprets the response as part of the diagnostic examination. Assume the full current study requirements are met.
Claim proposal
The draft contains the diagnostic study and a separate acute-airway inhalation-treatment entry for the same bronchodilator administration. The justification is that a medication was administered, although the record identifies its purpose as part of the diagnostic study.
Product distinction
The learner must evaluate the administration inclusion independently of any medication-product line. A separately reportable product, when supported, does not prove that an additional administration service occurred. Review the actual work rather than the drug’s possible uses in other clinical settings.
Your coding worksheet
- Identify diagnostic versus acute-treatment purpose.
- Locate the included bronchodilator administration.
- Evaluate the acute-treatment entry.
- Separate product review from administration review.
In your notebook, record the supported facts, your index route, the instructions you checked, and any missing detail that limits your answer.
Compare with the worked explanation
- This is a diagnostic response study.
- The bronchodilator is part of that completed study.
- NCCI J.7 does not permit adding acute-airway treatment for the same included administration.
- Medication-product reporting requires its own rules and does not remove the procedure inclusion.
Reference sections: J.7
Practice the linked chart questions
Review the lesson
Sources
- CMS — Medicare NCCI 2026 Chapter XI: Medicine and E/M. 2026. Accessed 2026-09-12.